Mr. Marc Edwards reports

KANE BIOTECH EXTENDS EXCLUSIVITY PERIOD ON ITS OFFER FOR ITS INTEREST IN STEM ANIMAL HEALTH

Kane Biotech Inc. has extended the exclusivity period on the offer for its interest in Stem Animal Health that it announced on Dec. 20, 2023, from March 19, 2024, until March 31, 2024.

Kane further announces that subsequent to the $625,000 (U.S.) deposit that it received at the time of the offer, Kane has received additional deposits totalling $900,000 (U.S.) which will be applied toward the sale price of Kane's interest in Stem.

About Kane Biotech Inc.

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.

We seek Safe Harbor.